2018, Jan. 13-15: Diagnostic Cytopathology Charleston, SC
January 13-15, 2018
15 CMEs / 14 SAMs
EYE OF THE NEEDLE: Core and FNA Insights
in Minimally Invasive Cytopathology
THIS COURSE HAS BEEN REDESIGNED!
Cytopathologists, in the era of genomic and personalized medicine, are expected to "do more with less" in specimen procurement, sample validation for diagnostic integrity, selection of ancillary tests (including molecular studies) and providing conduits to genetic testing. Small samples collected by image-guided fine needle aspiration biopsy, EBUS and mini-biopsies, and core extraction challenge professional expertise and are determinants of therapeutic pathways and patient outcomes.
This course has been revised to emphasize the procedural aspects of ultrasound-guided fine needle aspiration biopsies and to compare the appearance of samples in cellular and core histologic formats to optimize ancillary studies and rapid diagnoses. Additional organ systems have been included, primarily bone and soft tissue.
If you attended this course last year, there are so many reasons why you should come back, most importantly, the opportunity to learn pragmatic skills that you can immediately adapt to your practice to achieve improved patient care. And you can take your cytotech with you!
Recognizing that cytotechnologists contribute immeasurably to rapid on-site evaluation and extending the sphere of cytopathologists, USCAP is offering you the opportunity to invite your cytotechnologist to attend this conference at a reduced rate.
Molecular diagnostics are explored as basic science and as applications to diagnostic interpretations of cellular and tissue samples.
Challenge areas in diagnostic cytopathology are given particular attention - pancreas, liver, lung and kidney pathology is evolving in criteria, classification and nomenclature, and renal lesions have particular genomic and immunohistochemical profiles. Bone and soft tissue will be seen with a refreshing eye that engages the inquisitive and daring.
FNA biopsy has tremendously facilitated the evolution of patient-centered care, ensuring cytopathologists their place on health care delivery teams. Empathy and communication are dynamic elements that live at the pathologist-patient interface. Cultivation of both are explored in the context of managing errors and disclosures.
Whether you're a committed cytopathologist or a pathologist confronted with cytopathology in your general practice, this course will update your knowledge and stimulate your comprehension and confidence.
Charleston is a fantastic venue, a city of art, architecture, historical significance, culinary experiences, and exuberant people.
- Learn how therapeutically-useful information can be extracted from cellular samples and small biopsies utilizing cytomorphological, molecular and genetic techniques
- Enhance communication and empathy at the pathologist-patient interface
- Explore difficult areas of cytopathologic diagnosis in pancreas, kidney, lung, bone and soft tissue
- Become comfortable with molecular diagnostics applied to needle biopsies
- Understand the role of FNA biopsy in the evolution of empathetic patient-centered care
- Develop methods of practice improvement and quality improvement
- Discover that cytopathology is a community of diagnosticians dedicated to improvement of patient outcomes through specialized expertise
- Ivan A. Chebib, M.D., FRCPC
Massachusetts General Hospital / Harvard Medical School
- William Faquin, M.D., Ph.D.
Harvard Medical School
- Yaël K. Heher, M.D., MPH, FRCPC
Beth Israel Deaconess Medical Center / Harvard Medical School
- David B. Kaminsky, M.D., FIAC
United States and Canadian Academy of Pathology
- Sara E. Monaco, M.D.
University of Pittsburgh Medical Center
- Sinchita Roy-Chowdhuri, M.D., Ph.D.
University of Texas MD Anderson Cancer Center
- Edward Stelow, M.D.
University of Virginia Health System
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians can earn a maximum of 15 AMA PRA Category 1 Credits™ by participating in the CME activities within the 2018 Diagnostic Cytopathology Course.
USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Registrants must take and pass the post-test in order to claim SAMs credit.
Physicians can earn a maximum of 14 SAM credit hours.
USCAP records courses for future educational purposes. By registering for this conference, you consent that your likeness may be used by USCAP.